Biktarvy, formally known as bictegravir, represents a effective single-tablet therapy for managing HIV infection. This medication combines three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by inhibiting the HIV's ability to copy within the body, considerably reducing the viral burden. For many